Doxorubicin-containing MNA not checked
SkinJect, Inc. · 25 µg D-MNA · 50 µg D-MNA
FollowEvery change as it happens, and a Monday email
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “A 15 x 15 millimeter array containing 400 dissolvable microneedles delivering active agent”In the company’s words, NCT04928222 on ClinicalTrials.gov
- Tested for
- Basal Cell Carcinoma
- Main trialPhase 1/2
- “Part I is designed as a study of P-MNA application in healthy human volunteers. The goal of Part I is to determine several factors possibly affecting the rate and extent of microneedle array dissolution, such as anatomic location; age; duration of array exposure to the skin; and the criticality of proper array application to the skin. Part II will be a randomized study in which doxorubicin-containing arrays will be applied to subjects demonstrated by biopsy to have basal cell cancer. A subject will be randomized to one of four dose groups: placebo microneedle array and 50 µg, 100 µg, and 200…”In the company’s words, NCT04928222 on ClinicalTrials.gov
- Other names
- 25 µg D-MNA · 50 µg D-MNA · 100 µg D-MNA · 200 µg D-MNA
Other drugs for Basal Cell Carcinoma
- BO-112Highlight Therapeutics · Phase 2
- STAR0602Marengo Therapeutics, Inc. · Phase 1/2
- MDNA11Medicenna Therapeutics, Inc. · Phase 1/2
- PembrolizumabMerck & Co. · Phase 1/2
- Vusolimogene OderparepvecReplimune, Inc. · Phase 1/2
- CemiplimabRegeneron · Phase 2
Coming up0
No dates coming up.
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials2
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 1/2Active, not recruiting | 30 Dec 2023 | Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) | |
| Phase 1Terminated | 1 Mar 2021 | Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026